All-in-one platform for AI R&D in medical imaging, encompassing data collection, selection, annotation, and pre-processing

TL;DR

This paper introduces a comprehensive platform for medical imaging AI R&D that addresses data imbalance by including under-represented Asian data, offering ready-to-use datasets, and integrating advanced technologies like blockchain and generative AI.

Contribution

It presents the first commercial platform covering data collection, selection, annotation, and pre-processing, with a focus on Asian data and innovative data security and synthesis methods.

Findings

Established a platform with diverse Asian medical imaging data

Provided ready-to-use datasets for AI development

Plans to incorporate blockchain and generative AI for data security and synthesis

Abstract

Deep Learning is advancing medical imaging Research and Development (R&D), leading to the frequent clinical use of Artificial Intelligence/Machine Learning (AI/ML)-based medical devices. However, to advance AI R&D, two challenges arise: 1) significant data imbalance, with most data from Europe/America and under 10% from Asia, despite its 60% global population share; and 2) hefty time and investment needed to curate proprietary datasets for commercial use. In response, we established the first commercial medical imaging platform, encompassing steps like: 1) data collection, 2) data selection, 3) annotation, and 4) pre-processing. Moreover, we focus on harnessing under-represented data from Japan and broader Asia, including Computed Tomography, Magnetic Resonance Imaging, and Whole Slide Imaging scans. Using the collected data, we are preparing/providing ready-to-use datasets for medical AI R&D by 1) offering these datasets to AI firms, biopharma, and medical device makers and 2) using them as training/test data to develop tailored AI solutions for such entities. We also aim to merge Blockchain for data security and plan to synthesize rare disease data via generative AI. DataHub Website: https://medical-datahub.ai/